hotspot -WSS

hotspot

author：focus 2025-08-10 11:41:38 - browse：9736

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Van's Gluten Free Original Waffles recalled for possible wheat allergen

WSS

These geoengineering technologies could help combat the climate crisis, scientists say

How Long Island became the ‘eugenics capital of the world’

Drug firms test therapies to halt Alzheimer’s before symptoms arise

New case study details death in closely watched Alzhiemer's trial

Complete sequence of Y chromosome published for first time

Medicare explains how it will choose drugs for negotiation

focus

hotspot

explore

How one medical school became remarkably diverse

Inside the fall of star MIT scientist David Sabatini

DIEP, the 'gold standard' of breast reconstruction, is under threat

These geoengineering technologies could help combat the climate crisis, scientists say

Virginia high school admissions case could be legal follow

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Medicare proposal to cover medical devices draws a mixed reaction

Why more medical students aren't specializing in primary care

At least 13 dead in Texas as scorching temps continue

Listen: PBM conflicts, RSV vaccines, & the future of flu season

entertainment

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Grail is spending more than ever lobbying Congress

Why is France rioting? What to know about the fatal police shooting of Nahel M

Grail is spending more than ever lobbying Congress

What do new weight loss drugs mean for bariatric surgery?

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

focus

hotspot

hotspot

Wikipedia